--- title: "RemedyRepack Inc. Recalls: Agency-Reported Status and History (Oct 1, 2026) | Is It on Recall" description: "Search RemedyRepack Inc. recall records, lots, firms and dates. Reported status can be incomplete; use the linked agency notice for current instructions." url: https://isitonrecall.com/brand/remedyrepack-inc/ updated: 2026-10-01 site: "Is It on Recall" language: en --- [Home](https://isitonrecall.com/) / Brand archive # RemedyRepack Inc. recall records **5** reported ongoing 33 records in this archive. Latest source date Apr 22, 2025. FDA enforcement status can lag behind the recall lifecycle. An empty search or a reported termination is not a personal product-safety determination. Archive changed Oct 1, 2026. USDA FSIS records are unavailable; [check FSIS directly](https://www.fsis.usda.gov/recalls). [Source coverage and dates](https://isitonrecall.com/sources/). ## Records and reported status Apr 22, 2025 FDA drug enforcement ### [Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC#: 70518-3772-02](https://isitonrecall.com/recall/fda-drug-d-0411-2025-clindamycin-hcl-capsule-300-mg-qty-30-capsules-per-bottle-rx-only-repackaged-by-remedyrepack-inc-ind/) CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets. Class II Reported ongoing Distribution: Within U.S - PA, VA, FL. [Official source for Clindamycin HCl Capsule, 300 mg, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepac...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0411-2025%22) Mar 24, 2025 FDA drug enforcement ### [Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701. NDC; 70518-3772-00](https://isitonrecall.com/recall/fda-drug-d-0378-2025-clindamycin-hcl-300-mg-capsule-qty-30-capsules-per-bottle-rx-only-repackaged-by-remedyrepack-inc-ind/) CGMP Deviations Class II Reported ongoing Distribution: PA [Official source for Clindamycin HCl, 300 mg Capsule, QTY: 30 Capsules per bottle, Rx Only, Repackaged by: RemedyRepac...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0378-2025%22) Jan 24, 2025 FDA drug enforcement ### [Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, PA 1570...](https://isitonrecall.com/recall/fda-drug-d-0217-2025-carvedilol-25-mg-tablet-qty-30-tablets-per-blister-pack-3-x-10-blister-cards-rx-only-mfg-by-glenmark/) CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit. Class II Reported terminated Distribution: FL [Official source for Carvedilol 25 mg Tablet, QTY: 30 Tablets per Blister Pack (3 x 10 blister cards), Rx Only, MFG by...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0217-2025%22) Dec 2, 2024 FDA drug enforcement ### [Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 count bottles (NDC 70518-0937-03), Rx only, Source NDC 57237-0019-99, MFG: Risin...](https://isitonrecall.com/recall/fda-drug-d-0165-2025-duloxetine-delayed-release-capsules-60-mg-a-30-count-blister-cards-ndc-70518-0937-04-b-30-count-bott/) CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit. Class II Reported ongoing Distribution: Nationwide in the US [Official source for Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70518-0937-04), b) 30 ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0165-2025%22) Jun 26, 2024 FDA drug enforcement ### [Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx only, MFG: Glenmark, Mahwah, NJ 07430, Repackaged by: RemedyRepack Inc., Indiana, ...](https://isitonrecall.com/recall/fda-drug-d-0611-2024-potassium-chloride-micro-10meq-k-750-mg-extended-release-capsules-30-count-blister-card-rx-only-mfg/) CGMP Deviations: Out of specification for dissolution Class II Reported terminated Distribution: USA Nationwide [Official source for Potassium Chloride Micro 10mEq K (750 mg) Extended Release Capsules, 30-count blister card, Rx on...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0611-2024%22) May 31, 2024 FDA drug enforcement ### [Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laborator...](https://isitonrecall.com/recall/fda-drug-d-0549-2024-phenazopyridine-hcl-100mg-tablets-6-count-bottles-rx-only-repackaged-by-remedyrepack-inc-indiana-pa/) Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg. Class II Reported terminated Distribution: Product was distributed to one medical facility. [Official source for Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0549-2024%22) May 2, 2024 FDA drug enforcement ### [TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count blister pack, NDC 70518-3824-02; (a) 180-count blister pack, NDC 70518-3824-03;...](https://isitonrecall.com/recall/fda-drug-d-0489-2024-tramadol-hcl-50-mg-tablet-packaged-as-a-30-count-blister-pack-ndc-70518-3824-00-b-90-count-blister-p/) Presence of Foreign Tablets: Manufacturer received a report from a Pharmacist who reported finding a tablet of baclofen in a bottle of 1000-count tramadol Class II Reported terminated Distribution: Nationwide in the USA [Official source for TraMADol HCl 50 mg Tablet, Packaged as (a) 30-count blister pack, NDC 70518-3824-00; (b) 90-count...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0489-2024%22) May 1, 2023 FDA drug enforcement ### [LORazepam Injection, 2mg / mL Single Dose vial 1ml vial, Rx Only, MFG Akorn Lake Forest IL 60045, Repackaged by: RemedyRepack Inc., Indiana PA 15701, Source NDC # 17478-0040-01,...](https://isitonrecall.com/recall/fda-drug-d-0576-2023-lorazepam-injection-2mg-ml-single-dose-vial-1ml-vial-rx-only-mfg-akorn-lake-forest-il-60045-repackag/) CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess. Class II Reported terminated Distribution: Product was distrituded to three direct account in PA. [Official source for LORazepam Injection, 2mg / mL Single Dose vial 1ml vial, Rx Only, MFG Akorn Lake Forest IL 60045,...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0576-2023%22) May 1, 2023 FDA drug enforcement ### [Ketotifen Fumarate 0.025 %, Antihistamine eye drops, 5mL bottle, MFG: Akorn, Lake Forrest IL 60045, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-1142-00; Sourc...](https://isitonrecall.com/recall/fda-drug-d-0577-2023-ketotifen-fumarate-0-025-antihistamine-eye-drops-5ml-bottle-mfg-akorn-lake-forrest-il-60045-repackag/) CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess. Class II Reported ongoing Distribution: Product was distrituded to three direct account in PA. [Official source for Ketotifen Fumarate 0.025 %, Antihistamine eye drops, 5mL bottle, MFG: Akorn, Lake Forrest IL 6004...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0577-2023%22) May 1, 2023 FDA drug enforcement ### [Pyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card, NDC # 70518-2534-01; b) 1 x 100 UD box, NDC # 70518-2534-00, MFG: Akorn, Lake Forest, IL 60045, Repackaged by : R...](https://isitonrecall.com/recall/fda-drug-d-0578-2023-pyrazinamide-500-mg-tablet-packaged-in-a-29-x-30-count-card-ndc-70518-2534-01-b-1-x-100-ud-box-ndc-7/) CGMP Deviations: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess. Class II Reported ongoing Distribution: Product was distrituded to three direct account in PA. [Official source for Pyrazinamide, 500 mg Tablet, packaged in a) 29 x 30-count card, NDC # 70518-2534-01; b) 1 x 100 U...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0578-2023%22) Mar 20, 2023 FDA drug enforcement ### [Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2921-03](https://isitonrecall.com/recall/fda-drug-d-0490-2023-aripiprazole-5mg-tablets-30-count-bottles-rx-only-repackaged-by-remedyrepack-inc-indiana-pa-15701-nd/) cGMP Deviations Class II Reported terminated Distribution: RemedyRepack distributed product to consignees nationwide within the United States [Official source for Aripiprazole 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, P...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0490-2023%22) Mar 20, 2023 FDA drug enforcement ### [Atorvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-1946-00) and b) 90-count bottles (NDC 70518-1946-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, ...](https://isitonrecall.com/recall/fda-drug-d-0491-2023-atorvastatin-10-mg-tablets-packaged-in-a-30-count-bottles-ndc-70518-1946-00-and-b-90-count-bottles-n/) cGMP Deviations Class II Reported terminated Distribution: RemedyRepack distributed product to consignees nationwide within the United States [Official source for Atorvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-1946-00) and b) 90-count b...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0491-2023%22) Mar 20, 2023 FDA drug enforcement ### [Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC 70518-1560-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701.](https://isitonrecall.com/recall/fda-drug-d-0492-2023-doxazosin-2-mg-tablets-packaged-in-a-30-count-ndc-70518-1560-00-and-b-90-count-bottles-ndc-70518-156/) cGMP Deviations Class II Reported terminated Distribution: RemedyRepack distributed product to consignees nationwide within the United States [Official source for Doxazosin 2 mg tablets, packaged in a) 30-count (NDC 70518-1560-00) and b) 90-count bottles (NDC ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0492-2023%22) Mar 20, 2023 FDA drug enforcement ### [Glimepiride 2 mg tablets, packaged in a) 30-count bottles (NDC 70518-0405-03), b) 90-count bottles (NDC 70518-0405-00) and c)180-count bottles (NDC 70518-0405-02), Rx only, Repa...](https://isitonrecall.com/recall/fda-drug-d-0493-2023-glimepiride-2-mg-tablets-packaged-in-a-30-count-bottles-ndc-70518-0405-03-b-90-count-bottles-ndc-705/) cGMP Deviations Class II Reported terminated Distribution: RemedyRepack distributed product to consignees nationwide within the United States [Official source for Glimepiride 2 mg tablets, packaged in a) 30-count bottles (NDC 70518-0405-03), b) 90-count bottle...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0493-2023%22) Mar 20, 2023 FDA drug enforcement ### [Ropinirole 0.5 mg tablets, packaged in 90-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2439-00.](https://isitonrecall.com/recall/fda-drug-d-0494-2023-ropinirole-0-5-mg-tablets-packaged-in-90-count-bottles-rx-only-repackaged-by-remedyrepack-inc-indian/) cGMP Deviations Class II Reported terminated Distribution: RemedyRepack distributed product to consignees nationwide within the United States [Official source for Ropinirole 0.5 mg tablets, packaged in 90-count bottles, Rx only, Repackaged by: RemedyRepack Inc...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0494-2023%22) Mar 20, 2023 FDA drug enforcement ### [Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-3519-00.](https://isitonrecall.com/recall/fda-drug-d-0495-2023-rosuvastatin-5mg-tablets-30-count-bottles-rx-only-repackaged-by-remedyrepack-inc-indiana-pa-15701-nd/) cGMP Deviations Class II Reported terminated Distribution: RemedyRepack distributed product to consignees nationwide within the United States [Official source for Rosuvastatin 5mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, P...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0495-2023%22) Mar 20, 2023 FDA drug enforcement ### [Simvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-0064-01) and b) 90-count bottles (NDC 70518-0064-00), Rx only, Repackaged by: RemedyRepack Inc., Indiana, P...](https://isitonrecall.com/recall/fda-drug-d-0496-2023-simvastatin-10-mg-tablets-packaged-in-a-30-count-bottles-ndc-70518-0064-01-and-b-90-count-bottles-nd/) cGMP Deviations Class II Reported terminated Distribution: RemedyRepack distributed product to consignees nationwide within the United States [Official source for Simvastatin 10 mg tablets, packaged in a) 30-count bottles (NDC 70518-0064-01) and b) 90-count bo...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0496-2023%22) Mar 20, 2023 FDA drug enforcement ### [Tadalafil 5 mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC 70518-2972-00](https://isitonrecall.com/recall/fda-drug-d-0497-2023-tadalafil-5-mg-tablets-30-count-bottles-rx-only-repackaged-by-remedyrepack-inc-indiana-pa-15701-ndc/) cGMP Deviations Class II Reported terminated Distribution: RemedyRepack distributed product to consignees nationwide within the United States [Official source for Tadalafil 5 mg tablets, 30-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA ...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0497-2023%22) Mar 20, 2023 FDA drug enforcement ### [Atorvastatin 20 mg tablets, packaged in a) 30-count bottles (NDC 70518-1977-00) and b)90-count bottles (NDC 70518-1977-01), Rx only, Repackaged by: RemedyRepack Inc., Indiana, P...](https://isitonrecall.com/recall/fda-drug-d-0498-2023-atorvastatin-20-mg-tablets-packaged-in-a-30-count-bottles-ndc-70518-1977-00-and-b-90-count-bottles-n/) cGMP Deviations Class II Reported terminated Distribution: RemedyRepack distributed product to consignees nationwide within the United States [Official source for Atorvastatin 20 mg tablets, packaged in a) 30-count bottles (NDC 70518-1977-00) and b)90-count bo...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0498-2023%22) Mar 20, 2023 FDA drug enforcement ### [Ropinirole 2mg tablets, packaged in 180-count bottles, Rx only, Repackaged by: RemedyRepack Inc., Indiana, PA 15701, NDC70518-2750-00](https://isitonrecall.com/recall/fda-drug-d-0499-2023-ropinirole-2mg-tablets-packaged-in-180-count-bottles-rx-only-repackaged-by-remedyrepack-inc-indiana/) cGMP Deviations Class II Reported terminated Distribution: RemedyRepack distributed product to consignees nationwide within the United States [Official source for Ropinirole 2mg tablets, packaged in 180-count bottles, Rx only, Repackaged by: RemedyRepack Inc.,...](https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0499-2023%22) ## Reasons in these listed records - CGMP Deviations - products manufactured in a shared facility with Ezetimibe tablets. - CGMP Deviations - CGMP deviations: presence of N-Nitroso Carvedilol Impurity-1 (NNC 1), above the FDA recommended acceptable intake limit. - CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit. These examples come from this result page and are not a ranking of every recall reason. ## Checking RemedyRepack Inc. ### Is there a recall on remedyrepack inc. right now? This archive contains 33 records, including 5 with agency-reported ongoing status. The status field can be incomplete or stale. Open the current official notice and match your exact product. ### How do I check my package or product? Compare the product, firm and lot, date, model or serial identifiers with the notice. [Use the label-check guide](https://isitonrecall.com/guides/read-lot-codes/) if you need help locating an identifier. ### Does a matching name mean every item is included? A name is a search match. The agency notice sets the affected products and identifiers. Do not assume that every item with the same name or brand belongs to the recall. ### What if the search finds no matching record? This search has source and keyword limits. Missing records or a missing lot code do not establish that a product is unaffected. [Check source coverage](https://isitonrecall.com/sources/) and the agency's current notices. ### Where can I find older records? Use [monthly archives](https://isitonrecall.com/archives/) or the local search. The initial import covers records dated from October 2021 where available; each source's actual first and latest dates appear on the coverage page. ## Keep checking [Search RemedyRepack Inc.](https://isitonrecall.com/check/?q=RemedyRepack%20Inc.) [Browse related products](https://isitonrecall.com/products/) [Review source dates](https://isitonrecall.com/sources/)